1. Home
  2. ONC vs HUM Comparison

ONC vs HUM Comparison

Compare ONC & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • HUM
  • Stock Information
  • Founded
  • ONC 2010
  • HUM 1961
  • Country
  • ONC Switzerland
  • HUM United States
  • Employees
  • ONC N/A
  • HUM N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • HUM Medical Specialities
  • Sector
  • ONC Health Care
  • HUM Health Care
  • Exchange
  • ONC Nasdaq
  • HUM Nasdaq
  • Market Cap
  • ONC 37.3B
  • HUM 36.0B
  • IPO Year
  • ONC N/A
  • HUM 1993
  • Fundamental
  • Price
  • ONC $342.50
  • HUM $293.74
  • Analyst Decision
  • ONC Strong Buy
  • HUM Hold
  • Analyst Count
  • ONC 10
  • HUM 20
  • Target Price
  • ONC $340.70
  • HUM $288.33
  • AVG Volume (30 Days)
  • ONC 297.4K
  • HUM 2.5M
  • Earning Date
  • ONC 11-11-2025
  • HUM 10-29-2025
  • Dividend Yield
  • ONC N/A
  • HUM 1.25%
  • EPS Growth
  • ONC N/A
  • HUM N/A
  • EPS
  • ONC N/A
  • HUM 13.04
  • Revenue
  • ONC $4,562,002,000.00
  • HUM $123,110,000,000.00
  • Revenue This Year
  • ONC $896.81
  • HUM $10.08
  • Revenue Next Year
  • ONC N/A
  • HUM $5.10
  • P/E Ratio
  • ONC N/A
  • HUM $21.76
  • Revenue Growth
  • ONC 47.33
  • HUM 9.88
  • 52 Week Low
  • ONC $170.99
  • HUM $206.87
  • 52 Week High
  • ONC $355.30
  • HUM $315.35
  • Technical
  • Relative Strength Index (RSI)
  • ONC 57.00
  • HUM 62.35
  • Support Level
  • ONC $334.53
  • HUM $239.00
  • Resistance Level
  • ONC $355.30
  • HUM $261.91
  • Average True Range (ATR)
  • ONC 7.30
  • HUM 11.83
  • MACD
  • ONC 0.00
  • HUM 2.53
  • Stochastic Oscillator
  • ONC 61.75
  • HUM 97.40

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About HUM Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Share on Social Networks: